Coagulation Disorder, Inflammatory Bowel Diseases, Thromboembolism
Conditions
Brief summary
The main objective was to demonstrate the existence and importance of hypercoagulability in patients with IBD, by determining the prevalence of changes in coagulation parameters and evaluating the impact of these changes on the occurrence of thromboembolic events.
Interventions
No intervention was made
Sponsors
Portuguese IBD Group
Centro Hospitalar Tondela-Viseu
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patients with 18 years of age or older, diagnosed with IBD, followed at a gastroenterology consultation at Centro Hospitalar Tondela-Viseu, between November 2016 and April 2017.
Exclusion criteria
* Individuals with other risk factors for TE (severe hepatic or renal failure, valvular heart disease, atrial fibrillation, heart failure or cardiomyopathy, pregnancy, and oral anticoagulants or heparin at the baseline).
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Prevalence of thromboembolic events in IBD | 36 months | To evaluate the coagulation parameters and the prevalence of thromboembolic events in IBD patients |
| Coagulation parameters variations in IBD | 36 months | To investigate the correlation between coagulation parameters and disease phenotype and activity. |
Countries
Portugal
Outcome results
None listed